|
Index of reports
> Cases resulting in life threatening events (18)
> Cases with Angioedema (3)
Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in life threatening events where reactions include angioedema.
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-03-21
Patient:
Adverse reactions / side effects: Atelectasis, Blood Pressure Increased, Angioedema, Tongue Oedema, Tachycardia, Blood PH Decreased, Acidosis, Blood Bicarbonate Decreased, Asphyxia, Pco2 Increased, Face Oedema, Lung Disorder, Pharyngeal Oedema
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Essential Hypertension
Start date: 2005-12-16
End date: 2006-01-01
Altace
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2006-01-01
End date: 2006-12-01
Other drugs received by patient: Estracyt / 00327002 /; Anafranil; Dicetel / 00505101 /; Seresta; Noctamid; Tahor; Mupiderm
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Canada on 2007-02-23
Patient:
Adverse reactions / side effects: Angioedema, Face Oedema, Pharyngeal Oedema, Dysphonia, Swollen Tongue, Unevaluable Event
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Blood Pressure
Start date: 2000-01-01
End date: 2006-07-01
Crestor
Dosage: 20 mg, qd
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2001-01-01
End date: 2006-12-03
Other drugs received by patient: Aspirin; Multi-Vitamins; Calcium Citrate W / Vitamin D NOS; Hydrodiuril; Plavix; Adalat; Doxepin HCL; Epipen
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Canada on 2007-02-01
Patient:
Adverse reactions / side effects: Angioedema, Face Oedema, Pharyngeal Oedema, Dysphonia, Swollen Tongue
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Indication: Blood Pressure
Start date: 2000-01-01
End date: 2006-07-01
Crestor
Dosage: 20 mg, qd
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2001-01-01
End date: 2006-12-03
Other drugs received by patient: Aspirin; Multi-Vitamins; Calcium Citrate W / Vitamin D NOS; Hydrodiuril
|
